Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,030.00
-42.80 (-3.99%)
Jul 31, 2026, 3:30 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 94.48 billion as of July 31, 2026. Its market cap has increased by 8.43% in one year.
Market Cap
94.48B
Enterprise Value
110.43B
Revenue
50.04B
Ranking
n/a
PE Ratio
15.40
Stock Price
1,030.00
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 94.48B, an increase of 1,160.71%. That is a compound annual growth rate of 10.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 94.48B | 13.84% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 190.56B |
| NATCO Pharma | 166.55B |
| Cohance Lifesciences | 162.71B |
| Alembic Pharmaceuticals | 157.79B |
| Alivus Life Sciences | 134.49B |
| Akums Drugs and Pharmaceuticals | 101.14B |
| Sudeep Pharma | 96.71B |
| Sun Pharma Advanced Research Company | 67.64B |